By starting with the end in mind, and scaling down, this transformative technology reduces the variability in CQAs between and within the different stages of the drug development pipeline. It also reduces the risk of needing to reformulate. From the low shear micro mixing required for the production of mRNA loaded lipid nano particles; to dispersed biodegradable PLGA particles with a narrower size distribution, Micropore’s patented crossflow membrane technology is revolutionising the world of product formulation.
In pharmaceuticals and biopharmaceuticals, we do much more than the demanding micro- and nanoparticle injectables. Micropore has over 100 years of accumulated expertise in the formulation of different drug product delivery systems.
We can help you engineer your ideal delivery formulation whatever the method you choose:
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.
Server Render
Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.